Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

112.68 +1.21 (+1.09%)

Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

53 54 Next >

A Bullish Sign Appears On Abbott Laboratories's Chart ↗

January 24, 2023

Via Benzinga

Earnings Outlook For Abbott Laboratories ↗

January 24, 2023

Via Benzinga

Abbott Laboratories, QUALCOMM, GE HealthCare Technologies And This Subsidiary Of Diamondback Energy On CNBC's 'Final Trades' ↗

January 24, 2023

On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named Viper Energy Partners LP (NASDAQ: VNOM), which is a subsid

Via Benzinga

Stocks Make a Quiet Move Upward Ahead of Thursday's GDP, 'Pause' Talk ↗

January 23, 2023

(Monday Market Open) This week and next could go a long way toward determining how the current quarter plays out on Wall Street.

Via Benzinga

Spotify To Downsize Employee Count, Activist Investor Elliott Invests Multibillion Dollars In Salesforce, Abbott Draws DOJ Investigation On Baby Formula Plant Shutdown: Today's Top Stories ↗

January 23, 2023

Reuters Juul's Consumer Settlement Is 'Reasonable & Adequate,' US Judge Says

Via Benzinga

FDA Approves Abbott's Next-Gen Navitor TAVI System For Aortic Stenosis ↗

January 17, 2023

Via Benzinga

2 Best Healthcare Stocks to Buy Right Now ↗

January 05, 2023

Healthcare is a durable economic sector.

Via The Motley Fool

Want Safe and Growing Passive Income? Buy These 2 Dividend Kings In 2023 ↗

January 23, 2023

It doesn't get any safer for income investors than Dividend Kings.

Via The Motley Fool

6 Dividend Growth Stocks ↗

January 22, 2023

Interested in knowing about companies that are paying their shareholders even bigger dividends than before? Today I want to tell you about six dividend growth stocks that just increased their...

Via Talk Markets

Tesla, Microsoft, IBM, Intel, TI Among Companies Reporting This Week: Can Netflix's Optimism Spill Over To Rest Of Tech Space? ↗

January 22, 2023

Netflix, Inc. (NASDAQ: NFLX) shares jumped nearly 8.5% on Friday before settling at their highest level since April 19, 2022, when shares plunged after the company reported its first loss in net paid...

Via Benzinga

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,500 Today ↗

December 28, 2022

Via Benzinga

Abbott Laboratories Under DOJ Investigation Into 2022 Baby Formula Plant Shutdown: Report ↗

January 21, 2023

The Justice Department's consumer-protection branch is conducting an investigation into infant formula maker Abbott Laboratories (NYSE: ABT).

Via Benzinga

ABBOTT ALERT: Bragar Eagel & Squire, P.C. is Investigating Abbott Laboratories on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

January 19, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

3 Top Passive-Income Stocks to Own in 2023 ↗

January 19, 2023

These stocks can add safety and growth to your portfolio.

Via The Motley Fool

AbbVie Stock: Dividend King ABBV Overview

January 19, 2023

Via MarketBeat

J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps ↗

January 17, 2023

Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing.

Via Talk Markets

Zoetis, SL Green Realty, Abbott Laboratories And This Big Bank Reporting Earnings On Friday: CNBC's 'Final Trades' ↗

January 12, 2023

On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors named Zoetis Inc.

Via Benzinga

Should You Buy This Promising New Healthcare Stock? ↗

January 12, 2023

Shares of GE Healthcare began trading last week after the company completed its spinoff from General Electric.

Via The Motley Fool

3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off ↗

January 11, 2023

These three healthcare stocks all deliver dependable dividends, with yields of 3% or more.

Via The Motley Fool

Is Medtronic Stock Ready to Revive?

January 09, 2023

The world’s largest medical device maker Medtronic PLC (NYSE: MDT) stock has fallen since April 2022. However, shares may have bottomed out.

Via MarketBeat

Topics Economy

3 Reliable Dividend Stocks You Can Buy With $600 ↗

January 09, 2023

With products and services that many of us can't live without, these businesses are poised to deliver steadily rising dividend payouts.

Via The Motley Fool

5 Top Pharma Stocks of 2022 to Buy for the Long Haul ↗

January 06, 2023

The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks.

Via InvestorPlace

Alphabet And These 2 Healthcare Stocks Insiders Are Selling ↗

January 04, 2023

The Nasdaq Composite dropped around 80 points on the first trading day of 2023. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Beat the Dow Jones With This Unstoppable Dividend Stock ↗

January 03, 2023

This drugmaker is accustomed to outperforming the broader market.

Via The Motley Fool

12 Recession-Proof Stocks ↗

December 26, 2022

The stock market had a rough time in 2022. In this article, we are examining 12 dividend stocks whose recession-proof characteristics should enable them to keep growing their dividends in a bear market...

Via Talk Markets

2 Healthcare Stocks You Can Buy and Hold for the Next Decade ↗

December 24, 2022

These companies are safe havens during tough times, with above-average dividends.

Via The Motley Fool

3 Stocks on Santa's Nice List to Buy Before 2023 ↗

December 24, 2022

These stocks each offer something Santa would like.

Via The Motley Fool

2 Beaten-Down Growth Stocks Set to Rebound in 2023 ↗

December 22, 2022

It'd be a mistake to write off these two healthcare leaders.

Via The Motley Fool

2 Exceptional Dividend Growth Stocks to Buy Now ↗

December 20, 2022

These companies have histories of rapid payout increases and the means to continue them.

Via The Motley Fool

1 Passive Income Stock to Buy Today, and 1 to Avoid for Now ↗

December 18, 2022

Rising interest rates don't affect all passive income stocks equally.

Via The Motley Fool

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

53 54 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Abbott Laboratories (NY:ABT)

All News about Abbott Laboratories

Starting at $3.75/week.

Subscribe Today